Kingstone Companies, Inc. (NASDAQ: KINS) Q4 2020 earnings call dated Mar. 19, 2021
Corporate Participants:
Amanda Goldstein — Investor Relations Director
Barry B. Goldstein — Chairman and Chief Executive Officer
Scott Van Pelt — Chief Financial Officer
Meryl S. Golden — Chief Operating Officer
Analysts:
Paul Newsome — Piper Sandler — Analyst
Bob Farnam — Boenning and Scattergood — Analyst
Gabriel McClure — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) stock research summary | Q3 2021
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key
Listen On
